ICAM-1 as a marker of endothelial dysfunction in patients with coronary heart disease

被引:0
|
作者
Poreba, R [1 ]
Skoczynska, A [1 ]
Derkacz, A [1 ]
Turczyn, B [1 ]
Wojakowska, A [1 ]
机构
[1] Wroclaw Med Univ, Dept Internal Med Occupat Dis & Hypertens, Wroclaw, Poland
来源
FRONTIERS IN CORONARY ARTERY DISEASE | 2003年
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Endothelial dysfunction has been considered as a main factor in the development of coronary heart disease (CHD). The purpose of the study was to examine the endothelial function in patients suffering from stable CHD. Concentrations of soluble intracellular adhesion molecule-1 (sICAM-1.) and endothelin-1 (ET-1) by ELISA and nitric oxide (NO2-/NO3-) by colorimetric method were measured in serum or plasma of 28 men with angiographically documented CHD (mean age 51,2 6,0 years). Results were compared to obtained in 28 healthy male subjects (mean age 51,2 6,0 years), matched individually to the study group. Serum concentration of NO was lower in patients with CHD in comparison to control subjects (19,4 +/- 9,1 ng/ml vs. 25,6 +/- 10,7 ng/ml; p<0,05) whereas the serum concentration of sICAM-1 was higher in patients with CHD in comparison to control group (291,5 +/- 38,2 ng/ml vs. 261,2 +/- 42,5 ng/ml; p<0,01). Results of the study show that serum concentration of sICAM-1 similarly as NO could be a valuable and sensitive marker of endothelial dysfunction.
引用
收藏
页码:365 / 369
页数:5
相关论文
共 50 条
  • [1] Endothelial dysfunction in coronary heart disease
    McGorisk, GM
    Treasure, CB
    CURRENT OPINION IN CARDIOLOGY, 1996, 11 (04) : 341 - 350
  • [2] Aspirin resistance and endothelial dysfunction in patients with coronary heart disease
    Pamukcu, B.
    Onur, I.
    Oflaz, H.
    Goren, M. T.
    Bugra, Z.
    Umman, S.
    Meric, M.
    Nisanci, Y.
    EUROPEAN HEART JOURNAL, 2007, 28 : 713 - 713
  • [3] BIOCHEMICAL MARKERS OF ENDOTHELIAL DYSFUNCTION IN CORONARY HEART DISEASE PATIENTS
    Romanova, Valentyna
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 115 - 116
  • [4] Are elevated levels of soluble ICAM-1 a marker of chronic graft disease in heart transplant recipients?
    Campana, E
    Parlapiano, C
    Borgia, MC
    Papalia, U
    Laurenti, A
    Pantone, P
    Giovanniello, T
    Marangi, M
    Sanguigni, S
    ATHEROSCLEROSIS, 2000, 148 (02) : 293 - 295
  • [5] Coronary artery endothelial ICAM-1 and neutrophil adhesion in endocarditis.
    Herndon, B
    Clark, S
    Bennett, D
    Fiorella, R
    FASEB JOURNAL, 2001, 15 (04): : A355 - A355
  • [6] Value of ICAM-1 expression and soluble ICAM-1 level as a marker of activity in sarcoidosis
    Kim, DS
    Paik, SH
    Lim, CM
    Lee, SD
    Koh, Y
    Kim, WS
    Kim, WD
    CHEST, 1999, 115 (04) : 1059 - 1065
  • [7] ICAM-1 signaling in endothelial cells
    Charlotte Lawson
    Sabine Wolf
    Pharmacological Reports, 2009, 61 : 22 - 32
  • [8] Soluble VCAM-1 and E-selectin, but not ICAM-1 discriminate endothelial injury in patients with documented coronary artery disease
    Semaan, HB
    Gurbel, PA
    Anderson, JL
    Muhlestein, JB
    Carlquist, JF
    Horne, BD
    Serebruany, VL
    CARDIOLOGY, 2000, 93 (1-2) : 7 - 10
  • [9] Increased expression of ICAM-1 in a case of accelerated coronary artery disease after heart transplantation
    Ballantyne, CM
    Masri, BM
    Clubb, FJ
    Radovancevic, B
    Smith, CW
    Hawkins, HK
    Frazier, OH
    Willerson, JT
    TEXAS HEART INSTITUTE JOURNAL, 1996, 23 (04) : 293 - 295
  • [10] ICAM-1 signaling in endothelial cells
    Lawson, Charlotte
    Wolf, Sabine
    PHARMACOLOGICAL REPORTS, 2009, 61 (01) : 22 - 32